Seres Therapeutics, Inc. (MCRB)
15.65
+0.20
(+1.29%)
USD |
NASDAQ |
Jan 09, 16:00
15.52
-0.13
(-0.83%)
After-Hours: 20:00
Seres Therapeutics Research and Development Expense (Quarterly): 12.62M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Altimmune, Inc. | 14.93M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |
| Theriva Biologics, Inc. | 2.551M |
| Oragenics, Inc. | 0.9309M |